Peer Review reports
From: Incidence and associated factors of cetuximab-induced hypersensitivity infusion reactions in 1392 cancer patients treated in four French areas: a possible association with Lyme disease?
|28 Dec 2021||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|5 Jun 2022||Reviewed||Reviewer Report|
|25 Sep 2022||Reviewed||Reviewer Report - Shinya Suzuki|
|10 Oct 2022||Author responded||Author comments - Claire Carlier|
|Resubmission - Version 4|
|10 Oct 2022||Submitted||Manuscript version 4|
|17 Oct 2022||Editorially accepted|
|25 Nov 2022||Article published||10.1186/s12885-022-10192-4|
You can find further information about peer review here.